Canada sets probiotic labeling deadline
This article was originally published in The Tan Sheet
Executive Summary
Probiotic product claims must comply by April 2010 with guidance Health Canada approved in April, which the Canadian Food Inspection Agency recently added to its rules. In an Oct. 1 letter to industry, CFIA's Food Safety and Consumer Protection Directorate advised that labels, advertisements and Web sites must comply with the probiotic labeling guidance within six months. The Guide to Food Labeling and Advertising distinguishes between strain-specific and general claims. Health Canada prohibits misleading or vague claims, and science directly applicable to a particular food must support strain-specific claims. The agency noted no specific strains have been accepted, but it will update its online list of strain-specific claims as they are reviewed and accepted
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.